Icon
+91 94997 68112
Login Register

Zyrtec-D - (5 mg;120 mg, Tablet, Extended Release)

Cetirizine Hydrochloride and Pseudoephedrine Johnson And Johnson Group
5 mg;120 mg, Tablet, Extended Release
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
Less Than 5
Indicated for the relief of nasal and non-nasal symptoms associated with seasonal or perennial allergic rhinitis in adults and children 12 years of age and older.
Yes
**** ** *** ***** ** **** **** ** **** ****** * *** ** ********** *** ******* ******* ****. ******* **** ****** ** ******* ********* ******** ****** *** ********** ** ****** **** *** ***** *** *** **** *********** *** *********. *********** ******* ** ****, ****** ***** **** ** *** *** ********** *** ******* ******* ****** ** ****. ****** * ***** ***** *** ****** ** **** , *** *** ********* ******** ******** *** ******** *** *******. **** ***** ***** **** *** ******, *** ****** ******** ******** *** ******** *** *******. *** ****** *** ***** * **** ** ******* *** *** *** *********. ******* ** *** **** **** ******* ***** **** ** **** ******* '*** (**** **, ****), '*** (**** **, ****), '*** (**** **, ****), *** ***** * **** ******* *******. ** ****** **** **** ******* ****** ** **** ****.
Zyrtec-D Patent 1 Patent 2 Patent 3 Patent 4
**** *** ********* *** ********* *** ********* *** *********
****** *** ********* *** ********* *** ********* *** *********
*** ****** *** ********* *** ********* *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ ** *** ********* *** ********* ******** ******** ** *** **, ****
****** ** \ ** *** ********* *** ********* ******** ******** ** ***** *, ****
*** ****** ** \ ** *** ********* *** ********* ******** ******** ** **** **, ****
  1. *** *, **** : ***** **** ** *** ***** **** ****** *. ** ********** *** ******* ******* *** *******.
  2. *** **, **** : **** ******** ******** *** ******** *** *******.
  3. *** *, **** : ****** ******** ******** *** ******** *** *******.
  4. *** **, **** : *** ****** ******** ******** *** ******** *** *******.
  5. *** **, **** : ******* ******** *** ***** *** **** ** **** ******* '*** (**** **, ****), '*** (**** **, ****), '*** (**** **, ****).
  6. *** *, **** : *** ***** * **** ******* ******* ** ******** ***** ** ******* ******** ** *******.
  7. *** *, **** : ********** ********* **** *******

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.